Asian Pacific Journal of Cancer Prevention

  • 제16권14호
  • /
  • Pages.6135-6140
  • /
  • 2015
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Differential Diagnosis of Malignant Biliary Tract Cancer from Benign Tissues using Apparent Diffusion Coefficient Measurements with Diffusion Weighted Imaging in Asians

  • Zhao, Xu-Ya (Department of Interventional Radiology, Guizhou Cacer Hospital, Cacer Hospital of Guizhou Medical University) ;
  • Zhou, Shi (Department of Interventional Radiology, Guizhou Cacer Hospital, Cacer Hospital of Guizhou Medical University) ;
  • Wang, Da-Zhi (Department of Interventional Radiology, Guizhou Cacer Hospital, Cacer Hospital of Guizhou Medical University) ;
  • He, Wei (Department of Interventional Radiology, Guizhou Cacer Hospital, Cacer Hospital of Guizhou Medical University) ;
  • Li, Jun-Xiang (Department of Interventional Radiology, Guizhou Cacer Hospital, Cacer Hospital of Guizhou Medical University) ;
  • Zhang, Shuai (Department of Interventional Radiology, Guizhou Cacer Hospital, Cacer Hospital of Guizhou Medical University)
  • 발행 : 2015.09.02
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: The aim of this meta-analysis was to assess the efficacy of the apparent diffusion coefficient (ADC) value of diffusion-weighted MRI (DWI) for differentiating biliary tract cancer (BTC) from benign biliary tract diseases in Asians. Materials and Methods: We systematically searched Embase and PubMed prior to December 2014. Eight studies conducted in Asians met our predetermined inclusion criteria. Results: Our meta-analysis results showed that ADC values in BTC tissues were significantly lower than in benign biliary tract tissues (SMD = -1.54, 95%CI: -1.75~-1.33, P<0.001). Subgroup analysis based on the MRI machine type showed that the ADC values were consistent, accurate and reliable in the diagnosis of BTC when comparing cancer tissue vs. benign tissue under the Siemens 1.5 T/3.0 T, Philips 1.5 T/3.0 T, GE 1.5 T, and Toshiba 1.5 T types, respectively (all P<0.05). Further, ADC values were still consistent and accurate in the differential diagnosis of BTC under the b value of 800 and $1000s/mm^2$ (all P<0.05). Conclusions: Our findings supported potential clinical applications of DWI ADC values in differentiating BTC from benign biliary tract diseases in Asians.

키워드

참고문헌

  1. Akay S, Kocaoglu M, Emer O, et al (2013). Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms. J Med Imaging Radiat Oncol, 57, 274-82. https://doi.org/10.1111/1754-9485.12026
  2. Attariwala R, Picker W (2013). Whole body MRI: improved lesion detection and characterization with diffusion weighted techniques. J Magn Reson Imaging, 38, 253-68. https://doi.org/10.1002/jmri.24285
  3. Baheti AD, Tirumani SH, Rosenthal MH, et al (2014). Diagnosis and management of intrahepatic cholangiocarcinoma: a comprehensive update for the radiologist. Clin Radiol, 69, 463-70. https://doi.org/10.1016/j.crad.2014.08.003
  4. Castro FA, Koshiol J, Hsing AW, et al (2013). Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic site. Int J Cancer, 133, 1664-71. https://doi.org/10.1002/ijc.28161
  5. Charatcharoenwitthaya P, Enders FB, Halling KC, et al (2008). Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatol, 48, 1106-17. https://doi.org/10.1002/hep.22441
  6. Chen H, Manning AK, Dupuis J (2012). A method of moments estimator for random effect multivariate meta-analysis. Biometrics, 68, 1278-84. https://doi.org/10.1111/j.1541-0420.2012.01761.x
  7. Chen LD, Xu HX, Xie XY, et al (2008). Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Radiol, 81, 881-9. https://doi.org/10.1259/bjr/22318475
  8. Donati OF, Chong D, Nanz D, et al (2014). Diffusion-weighted MR imaging of upper abdominal organs: field strength and intervendor variability of apparent diffusion coefficients. Radiol, 270, 454-63. https://doi.org/10.1148/radiol.13130819
  9. Furuse J, Kasuga A, Takasu A, et al (2012). Role of chemotherapy in treatments for biliary tract cancer. J Hepatobiliary Pancreat Sci, 19, 337-41. https://doi.org/10.1007/s00534-011-0494-2
  10. Gourgiotis S, Kocher HM, Solaini L, et al (2008). Gallbladder cancer. Am J Surg, 196, 252-64. https://doi.org/10.1016/j.amjsurg.2007.11.011
  11. Heijmen L, Verstappen MC, Ter Voert EE, et al (2012). Tumour response prediction by diffusion-weighted MR imaging: ready for clinical use? Crit Rev Oncol Hematol, 83, 194-207. https://doi.org/10.1016/j.critrevonc.2011.12.008
  12. Hsing AW, Sakoda LC, Rashid A, et al (2008). Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. Cancer Res, 68, 6442-52. https://doi.org/10.1158/0008-5472.CAN-08-0444
  13. Irie H, Kamochi N, Nojiri J, et al (2011). High b-value diffusionweighted MRI in differentiation between benign and malignant polypoid gallbladder lesions. Acta radiologica (Stockholm, Sweden : 1987), 52, 236-40. https://doi.org/10.1258/ar.2010.100234
  14. Jang KM, Kim SH, Lee SJ, et al (2013). Added value of diffusion-weighted MR imaging in the diagnosis of ampullary carcinoma. Radiol, 266, 491-501. https://doi.org/10.1148/radiol.12121106
  15. Kang TW, Kim SH, Park HJ, et al (2013). Differentiating xanthogranulomatous cholecystitis from wall-thickening type of gallbladder cancer: Added value of diffusionweighted MRI. Clinical Radiol, 68, 992-1001. https://doi.org/10.1016/j.crad.2013.03.022
  16. Khoo MM, Tyler PA, Saifuddin A, et al (2011). Diffusionweighted imaging (DWI) in musculoskeletal MRI: a critical review. Skeletal Radiol, 40, 665-81. https://doi.org/10.1007/s00256-011-1106-6
  17. Kim JH, Byun JH, Lee SJ, et al (2012). Differential diagnosis of sclerosing cholangitis with autoimmune pancreatitis and periductal infiltrating cancer in the common bile duct at dynamic CT, endoscopic retrograde cholangiography and MR cholangiography. Eur Radiol, 22, 2502-13. https://doi.org/10.1007/s00330-012-2507-1
  18. Kim SJ, Lee JM, Kim H, et al (2013a). Role of diffusionweighted magnetic resonance imaging in the diagnosis of gallbladder cancer. J Magn Reson Imag, 38, 127-37. https://doi.org/10.1002/jmri.23956
  19. Kim SJ, Lee JM, Kim H, et al (2013b). Role of diffusionweighted magnetic resonance imaging in the diagnosis of gallbladder cancer. J Magn Reson Imag, 38, 127-37. https://doi.org/10.1002/jmri.23956
  20. Kyriazi S, Collins DJ, Morgan VA, et al (2010). Diffusionweighted imaging of peritoneal disease for noninvasive staging of advanced ovarian cancer. Radiographics, 30, 1269-85. https://doi.org/10.1148/rg.305105073
  21. Lambrecht M, Van Calster B, Vandecaveye V, et al (2014). Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma. Radiother Oncol, 110, 429-34. https://doi.org/10.1016/j.radonc.2014.01.004
  22. Le Bihan D (2013). Apparent diffusion coefficient and beyond: what diffusion MR imaging can tell us about tissue structure. Radiol, 268, 318-22. https://doi.org/10.1148/radiol.13130420
  23. Lee NK, Kim S, Kim GH, et al (2012). Diffusion-weighted imaging of biliopancreatic disorders: correlation with conventional magnetic resonance imaging. World J Gastroenterol, 18, 4102-17. https://doi.org/10.3748/wjg.v18.i31.4102
  24. Lee NK, Kim S, Kim TU, et al (2014a). Diffusion-weighted MRI for differentiation of benign from malignant lesions in the gallbladder. Clin Radiol, 69, 78-85. https://doi.org/10.1016/j.crad.2013.09.017
  25. Lee NK, Kim S, Kim TU, et al (2014b). Diffusion-weighted MRI for differentiation of benign from malignant lesions in the gallbladder. Clin Radiol, 69, 78-85. https://doi.org/10.1016/j.crad.2013.09.017
  26. Li B, Li Q, Nie W, et al (2014). Diagnostic value of wholebody diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a metaanalysis. Eur J Radiol, 83, 338-44. https://doi.org/10.1016/j.ejrad.2013.11.017
  27. Low RN, Sebrechts CP, Barone RM, et al (2009). Diffusionweighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings--a feasibility study. AJR Am J Roentgenol, 193, 461-70. https://doi.org/10.2214/AJR.08.1753
  28. Malayeri AA, El Khouli RH, Zaheer A, et al (2011). Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up. Radiographics, 31, 1773-91. https://doi.org/10.1148/rg.316115515
  29. Morizane C, Okusaka T, Mizusawa J, et al (2013). Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805). Cancer Sci, 104, 1211-6. https://doi.org/10.1111/cas.12218
  30. Ogawa T, Horaguchi J, Fujita N, et al (2012). High b-value diffusion-weighted magnetic resonance imaging for gallbladder lesions: Differentiation between benignity and malignancy. J Gastroenterol, 47, 1352-60. https://doi.org/10.1007/s00535-012-0604-1
  31. Onur MR, Ozturk F, Aygun C, et al (2012). Role of the apparent diffusion coefficient in the differential diagnosis of gastric wall thickening. J Magn Reson Imaging, 36, 672-7. https://doi.org/10.1002/jmri.23698
  32. Padhani AR, Liu G, Koh DM, et al (2009). Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia, 11, 102-25. https://doi.org/10.1593/neo.81328
  33. Park HJ, Kim SH, Jang KM, et al (2014). The role of diffusionweighted MR imaging for differentiating benign from malignant bile duct strictures. Eur Radiol, 24, 947-58. https://doi.org/10.1007/s00330-014-3097-x
  34. Peters JL, Sutton AJ, Jones DR, et al (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA, 295, 676-80. https://doi.org/10.1001/jama.295.6.676
  35. Queiroz MA, Hullner M, Kuhn F, et al (2014). Use of diffusionweighted imaging (DWI) in PET/MRI for head and neck cancer evaluation. Eur J Nucl Med Mol Imaging, 41, 2212-21. https://doi.org/10.1007/s00259-014-2867-7
  36. Randi G, Malvezzi M, Levi F, et al (2009). Epidemiology of biliary tract cancers: an update. Ann Oncol, 20, 146-59.
  37. Shin HR, Oh JK, Masuyer E, et al (2010). Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia. Asian Pac J Cancer Prev, 11, 1159-66.
  38. Solak A, Solak I, Genc B, et al (2013). The role of diffusionweighted examination in non-polyploid gallbladder malignancies: A preliminary study. Turkish J Gastroenterol, 24, 148-53. https://doi.org/10.4318/tjg.2013.0659
  39. Somford DM, Hambrock T, Hulsbergen-van de Kaa CA, et al (2012). Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score
  40. Sterne JA, Egger M (2001). Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol, 54, 1046-55. https://doi.org/10.1016/S0895-4356(01)00377-8
  41. Sugita R, Yamazaki T, Furuta A, et al (2009a). High b-value diffusion-weighted MRI for detecting gallbladder carcinoma: Preliminary study and results. Eur Radiol, 19, 1794-8. https://doi.org/10.1007/s00330-009-1322-9
  42. Sugita R, Yamazaki T, Furuta A, et al (2009b). High b-value diffusion-weighted MRI for detecting gallbladder carcinoma: preliminary study and results. Eur Radiol, 19, 1794-8. https://doi.org/10.1007/s00330-009-1322-9
  43. Tan CH, Lim KS (2013). MRI of gallbladder cancer. Diagn Interv Radiol, 19, 312-9.
  44. Vilana R, Forner A, Bianchi L, et al (2010). Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatol, 51, 2020-9. https://doi.org/10.1002/hep.23600
  45. Wen H, Yoo SS, Kang J, et al (2010). A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer. J Hepatol, 52, 228-33. https://doi.org/10.1016/j.jhep.2009.11.002
  46. Whiting PF, Weswood ME, Rutjes AW, et al (2006). Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol, 6, 9. https://doi.org/10.1186/1471-2288-6-9
  47. Wu LM, Xu JR, Lu Q, et al (2013). A pooled analysis of diffusion-weighted imaging in the diagnosis of hepatocellular carcinoma in chronic liver diseases. J Gastroenterol Hepatol, 28, 227-34. https://doi.org/10.1111/jgh.12054
  48. Yoshioka M, Watanabe G, Uchinami H, et al (2013). Diffusionweighted MRI for differential diagnosis in gallbladder lesions with special reference to ADC cut-off values. Hepato-Gastroenterol, 60, 692-8.